The Science Generation project which European research commissioner Philippe Busquin is presenting in Brussels today aims to make decision-makers, politicians and scientists, as well as the general public, better informed on action to be taken at the interface between life sciences and society. This project, receiving €1.44 million in EU funding, seeks to set up networks of scientists, students and journalists, extending into the regions, with colloquia and public opinion surveys and debates online and in the field. The brainchild of the Aventis-Institut de France Foundation, the scheme is part of the Commissions efforts to bring science and society together in the framework of the European Research Area. "We are not just saying that it is important to have a wide public debate on life sciences. We are giving it concrete support", Commissioner Busquin said. "Science is moving very fast. It is giving many people hope, but many are afraid of it too. This is a situation which involves the responsibility of both scientists and public bodies. The purpose of Science Generation is to give the public a say in the development of life sciences so they can freely express their expectations and concerns. Now more than ever this dialogue has to take place at the European level as well, benefiting from cultural diversity and intercultural exchange", Mr Busquin concluded.
The principle of public debate on life sciences is at the heart of several Commission objectives: the creation of a European Research Area (ERA) going hand in hand with a European shared values area; the responsible development of life sciences, for which the Commission presented a strategic action plan in January 2002 ; and bringing researchers together with economic, social and political decision makers, the object of another action plan launched by the Commission in December 2001 .
Science Generation has been a remarkable success in France. Launched there as a pilot project two years ago, with European Commission support through its Fifth Research Framework Programme, it is going to be extended to other EU Member States, in particular Italy and Sweden, in a partnership with the Euro-CASE (European Council of Applied Sciences and Engineering) network comprising 18 applied sciences and technology academies.
Netties speak their mind, experts respond
This regional mobilisation is also reflected on the Science Generation website, www.science-generation.com. The site offers online debates on matters of public concern. Forthcoming issues will be "access to healthcare in southern hemisphere countries" and "therapeutic versus reproductive cloning".
For more information on:
- the Commissions communication "Life sciences and biotechnology: a Strategy for Europe": http://europa.eu.int/eur-lex/en/com/cnc/2002/com2002_0027en01.pdf
- the Science and Society action plan "Structuring the European Research Area": http://www.cordis.lu/rtd2002/science-society/home.html
- the Eurobarometer study of Europeans views on science and technology: http://europa.eu.int/comm/research/rtdinfo/fr/special-eurobarometre/index.html
- Biosociety, the Internet site which brings out the socio-economic and ethical implications of life sciences research: http://biosociety.cordis.lu/
- the Science Generation project: www.science-generation.com
Fabio FABBI: 02 2964174 - Lone MIKKELSEN : 02 2960567
Fabio Fabbi | Europäische Kommission
Selectively Reactivating Nerve Cells to Retrieve a Memory
01.06.2020 | Universität Heidelberg
CeMM study reveals how a master regulator of gene transcription operates
01.06.2020 | CeMM Forschungszentrum für Molekulare Medizin der Österreichischen Akademie der Wissenschaften
In living cells, enzymes drive biochemical metabolic processes enabling reactions to take place efficiently. It is this very ability which allows them to be used as catalysts in biotechnology, for example to create chemical products such as pharmaceutics. Researchers now identified an enzyme that, when illuminated with blue light, becomes catalytically active and initiates a reaction that was previously unknown in enzymatics. The study was published in "Nature Communications".
Enzymes: they are the central drivers for biochemical metabolic processes in every living cell, enabling reactions to take place efficiently. It is this very...
Early detection of tumors is extremely important in treating cancer. A new technique developed by researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from normal tissue. The work is published May 25 in the journal Nature Nanotechnology.
researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from...
Microelectronics as a key technology enables numerous innovations in the field of intelligent medical technology. The Fraunhofer Institute for Biomedical Engineering IBMT coordinates the BMBF cooperative project "I-call" realizing the first electronic system for ultrasound-based, safe and interference-resistant data transmission between implants in the human body.
When microelectronic systems are used for medical applications, they have to meet high requirements in terms of biocompatibility, reliability, energy...
Thomas Heine, Professor of Theoretical Chemistry at TU Dresden, together with his team, first predicted a topological 2D polymer in 2019. Only one year later, an international team led by Italian researchers was able to synthesize these materials and experimentally prove their topological properties. For the renowned journal Nature Materials, this was the occasion to invite Thomas Heine to a News and Views article, which was published this week. Under the title "Making 2D Topological Polymers a reality" Prof. Heine describes how his theory became a reality.
Ultrathin materials are extremely interesting as building blocks for next generation nano electronic devices, as it is much easier to make circuits and other...
Scientists took a leukocyte as the blueprint and developed a microrobot that has the size, shape and moving capabilities of a white blood cell. Simulating a blood vessel in a laboratory setting, they succeeded in magnetically navigating the ball-shaped microroller through this dynamic and dense environment. The drug-delivery vehicle withstood the simulated blood flow, pushing the developments in targeted drug delivery a step further: inside the body, there is no better access route to all tissues and organs than the circulatory system. A robot that could actually travel through this finely woven web would revolutionize the minimally-invasive treatment of illnesses.
A team of scientists from the Max Planck Institute for Intelligent Systems (MPI-IS) in Stuttgart invented a tiny microrobot that resembles a white blood cell...
19.05.2020 | Event News
07.04.2020 | Event News
06.04.2020 | Event News
29.05.2020 | Materials Sciences
29.05.2020 | Materials Sciences
29.05.2020 | Power and Electrical Engineering